183 related articles for article (PubMed ID: 35307561)
1. SUsceptibility and Resistance to Fosfomycin and other antimicrobial agents among pathogens causing lower urinary tract infections: findings of the SURF study.
Tutone M; Bjerklund Johansen TE; Cai T; Mushtaq S; Livermore DM
Int J Antimicrob Agents; 2022 May; 59(5):106574. PubMed ID: 35307561
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility to Fosfomycin and Nitrofurantoin of ESBL-Positive
Park KS; Kim DR; Baek JY; Shin A; Kim KR; Park H; Son S; Cho H; Kim YJ
J Korean Med Sci; 2023 Dec; 38(48):e361. PubMed ID: 38084025
[TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibility of Escherichia coli strains isolated from urine samples obtained in mainland China to fosfomycin trometamol and other antibiotics: a 9-year surveillance study (2004-2012).
Lai B; Zheng B; Li Y; Zhu S; Tong Z
BMC Infect Dis; 2014 Feb; 14():66. PubMed ID: 24502648
[TBL] [Abstract][Full Text] [Related]
4. Community-Acquired Uropathogenic
Carmona-Cartaya Y; Hidalgo-Benito M; Borges-Mateus LM; Pereda-Novales N; González-Molina MK; Quiñones-Pérez D
MEDICC Rev; 2022 May; 24(2):20-25. PubMed ID: 35648059
[TBL] [Abstract][Full Text] [Related]
5. High antimicrobial resistance in urinary tract infections in male outpatients in routine laboratory data, Germany, 2015 to 2020.
Salm J; Salm F; Arendarski P; Kramer TS
Euro Surveill; 2022 Jul; 27(30):. PubMed ID: 35904060
[TBL] [Abstract][Full Text] [Related]
6. Rapid detection of fosfomycin resistance in Escherichia coli and Klebsiella spp. strains isolated from urinary tract infections.
Kansak N; Arıcı N; Adaleti R; Nakipoglu Y; Aksaray S
J Microbiol Methods; 2021 Sep; 188():106296. PubMed ID: 34333048
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic Resistance Patterns Among Uropathogens in Female Outpatients Affected by Uncomplicated Cystitis: Focus on Fosfomycin Trometamol.
Cai T; Verze P; Arcaniolo D; Pandolfo SD; Smarrazzo F; Manfredi C; Tascini C; Caciagli P; Lanzafame M; De Sio M; Wagenlehner F; Johansen TEB; Palmieri A
Int J Antimicrob Agents; 2023 Nov; 62(5):106974. PubMed ID: 37739241
[TBL] [Abstract][Full Text] [Related]
8. Reversion of High-level Mecillinam Resistance to Susceptibility in Escherichia coli During Growth in Urine.
Thulin E; Thulin M; Andersson DI
EBioMedicine; 2017 Sep; 23():111-118. PubMed ID: 28855073
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Accuracy Of Rapid Fosfomycin Np Test For Detection Of Fosfomycin Resistance In Escherichia Coli In A Tertiary Care Hospital In Pakistan.
Yunus F; Hussain A; Mirza IA; Hanif F; Hussain W; Satti L; Khursheed U
J Ayub Med Coll Abbottabad; 2021; 33(4):668-672. PubMed ID: 35124928
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterisation of fosfomycin resistance in Escherichia coli urinary tract infection isolates from Australia.
Mowlaboccus S; Daley D; Pang S; Gottlieb T; Merlino J; Nimmo GR; George N; Korman TM; Streitberg R; Robson J; Peachey G; Collignon P; Bradbury S; Colombi E; Ramsay JP; Rogers BA; Coombs GW
Int J Antimicrob Agents; 2020 Oct; 56(4):106121. PubMed ID: 32739475
[TBL] [Abstract][Full Text] [Related]
11.
Chavan R; Naphade B; Waykar B; Bhagwat S
Microb Drug Resist; 2021 May; 27(5):678-684. PubMed ID: 33983854
[No Abstract] [Full Text] [Related]
12. Antibiotic susceptibility and fosfomycin resistance characterization in a cohort of children older than 6 years of age with urinary tract infection.
Garcia-Fulgueiras V; Caiata L; Bado I; Giachetto G; Robino L
Rev Argent Microbiol; 2022; 54(2):120-124. PubMed ID: 34154873
[TBL] [Abstract][Full Text] [Related]
13. Impact of reflex fosfomycin susceptibility testing on the utilization of carbapenems for definitive extended-spectrum β-lactamase Escherichia coli urinary tract infection treatment.
Deemer K; Grey J; Fronczek C; Marr K
Am J Health Syst Pharm; 2020 Nov; 77(Supplement_4):S105-S110. PubMed ID: 32840305
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo antibacterial activity of nitrofurantoin against clinical isolates of E. coli in Japan and evaluation of biological cost of nitrofurantoin resistant strains using a mouse urinary tract infection model.
Nakagawa S; Kurimoto Y; Ezumi M; Nakatani K; Mizunaga S; Yamagishi Y; Mikamo H
J Infect Chemother; 2021 Feb; 27(2):250-255. PubMed ID: 33060044
[TBL] [Abstract][Full Text] [Related]
15. Rediscovering the value of fosfomycin trometamol in the era of antimicrobial resistance: A systematic review and expert opinion.
Cai T; Novelli A; Tascini C; Stefani S
Int J Antimicrob Agents; 2023 Dec; 62(6):106983. PubMed ID: 37748624
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial Activity of Gepotidacin Tested against Escherichia coli and Staphylococcus saprophyticus Isolates Causing Urinary Tract Infections in Medical Centers Worldwide (2019 to 2020).
Arends SJR; Butler D; Scangarella-Oman N; Castanheira M; Mendes RE
Antimicrob Agents Chemother; 2023 Apr; 67(4):e0152522. PubMed ID: 36877017
[TBL] [Abstract][Full Text] [Related]
17. Raising the alarm: fosfomycin resistance associated with non-susceptible inner colonies imparts no fitness cost to the primary bacterial uropathogen.
Bermudez TA; Brannon JR; Dudipala N; Reasoner S; Morales G; Wiebe M; Cecala M; DaCosta M; Beebout C; Amir O; Hadjifrangiskou M
Antimicrob Agents Chemother; 2024 Jan; 68(1):e0080323. PubMed ID: 38078906
[TBL] [Abstract][Full Text] [Related]
18. Frequency Of Uropathogens Showing Resistance To Nitrofurantoin.
Tariq TM
J Pak Med Assoc; 2023 Jul; 73(7):1495-1497. PubMed ID: 37469065
[TBL] [Abstract][Full Text] [Related]
19. First Detection of
Nigiz Ş; Hazırolan G; Köseoglu Eser Ö; Gür D
Microb Drug Resist; 2022 Mar; 28(3):317-321. PubMed ID: 34851744
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial Resistance Trends of
Milano A; Sulejmani A; Intra J; Sala MR; Leoni V; Carcione D
Microb Drug Resist; 2022 Jan; 28(1):63-72. PubMed ID: 34520265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
